Skip to main content

Harlan M. Krumholz

  • Genomic Surveillance

    On the latest episode of the Health & Veritas podcast, Howard Forman and Harlan Krumholz are joined by Yale epidemiologist Nathan Grubaugh. They discuss the utility of rapid antigen tests and Grubaugh’s work tracking the evolution of COVID-19 variants.

    A rendering of the virus that causes COVID-19
  • From COVID or with COVID?

    On the latest episode of the Health & Veritas podcast, Howard Forman and Harlan Krumholz talk about the patients who test positive for COVID-19 after being admitted to the hospital for something else, and other health issues in the news, including the explosion in healthcare spending last year, a controversial Alzheimer’s drug, and the consequences of underinsurance in the United States. 

    Staff at a VA hospital in West Roxbury, Massachusetts, this week. 
  • The Latest on Omicron

    On the latest episode of the Health & Veritas podcast, Howard Forman and Harlan Krumholz discuss the state of the omicron surge and what we know and don’t know about the variant. Then they’re joined by Yale scientist Anne Wyllie, whose new research casts doubt on the ability of rapid antigen tests to detect asymptomatic omicron infections.

    A sign at a drugstore reading "We are out of COVID tests. We don't know when our next shipment will be. We also do not know who does have them."
  • A Wider View of COVID-19

    On the latest episode of the Health & Veritas podcast, Howard Forman and Harlan Krumholz are joined by Dr. Albert Ko, a Yale epidemiologist who has advised Connecticut governor Ned Lamont. They discuss the state of the pandemic, rebuilding global public health infrastructure, and what omicron tells us about future variants.

    A COVID-19 treatment center in Rio de Janeiro in December 2021
  • Taming Healthcare Costs

    In the latest episode of the Health & Veritas podcast,  Howard Forman and Harlan Krumholz are joined by Yale SOM economist Fiona Scott Morton, an expert on competition in healthcare and other industries. They discuss the forces driving up healthcare costs in the U.S. and the steps that Scott Morton and her colleagues have proposed to bring them under control.

    Outside an emergency department at night
  • Long COVID

    In the latest episode of the Health & Veritas podcast,  Howard Forman and Harlan Krumholz are joined by Liza Fisher to talk about her experience navigating the medical system and advocating for patients while enduring 18 months of debilitating COVID symptoms. 

    A COVID patient partly hidden by a curat Bellville Medical Center in Texas in September 2021.
  • The Drug Approval Process

    In the latest episode of the Health & Veritas podcast,  Howard Forman and Harlan Krumholz discuss what we know and don’t know about the newly identified omicron variant. Then they’re joined by Yale’s Dr. Joseph Ross to discuss the strengths and weaknesses of the FDA’s process for approving new drugs. 

    A sign outside the Food and Drug Administration
  • AI, Machine Learning, and Medicine

    On the latest episode of the Health & Veritas podcast, Howard Forman and Harlan Krumholz are joined by Dr. Rohan Khera, a Yale cardiologist whose research interests include the use of advanced data science tools to improve diagnosis and treatment. They discuss how artificial intelligence and machine learning can supplement human expertise in summarizing current literature, interpreting an electrocardiogram, and other areas. 

    An image of an electrocardiogram rendered in digital form
  • Health Economics

    On the latest episode of the Health & Veritas podcast, Howard Forman and Harlan Krumholz are joined by Jason Abaluck, a health economist at Yale SOM. They discuss a massive study co-authored by Abaluck that showed that masks reduce COVID infections in a community setting. 

    Men in Bangladesh wearing a masks provided as part of a study co-authored by Jason Abaluck.
  • The Saliva Test

    On the latest episode of the Health & Veritas podcast, Howard Forman and Harlan Krumholz are joined by Anne Wyllie, the Yale scientist who developed the SalivaDirect test for COVID-19. They discuss the development of the technology and its potential for enabling easier testing in a variety of communities. 

    A COVID testing site in the NBA "bubble" in Orlando, Florida, in July 2020.